Nasdaq said on January 10, 2026 that Walmart will replace AstraZeneca in the Nasdaq-100, Nasdaq-100 Equal Weighted, and Nasdaq-100 Ex‑Tech Sector indexes before market open on January 20, 2026. Walmart announced in November it would shift its primary listing from the New York Stock Exchange to Nasdaq. The change alters index composition and affects funds tracking those indexes.
Key Points
- 1Replaces: Walmart will join the Nasdaq-100, replacing AstraZeneca effective before market open January 20, 2026
- 2Explains: Walmart moved its primary listing from NYSE to Nasdaq citing investor alignment and cost savings
- 3Implication: Inclusion changes index composition, affecting index funds and passive investors' holdings and flows
Scoring Rationale
Official Nasdaq announcement and direct investor impact justify score, limited by minor novelty and low AI relevance.
Sources
Public references used for this report.
Practice with real FinTech & Trading data
90 SQL & Python problems · 15 industry datasets
Used by DS/ML engineers at top companies
Active Verified Users by Income TierEasyTechnology Stocks with High BetaMediumPortfolio Performance ScorecardHard
250 free problems · No credit card
See all FinTech & Trading problems
